论文部分内容阅读
概述流行性出血热(EHF)是一种急性传染病,在我国流行十分广泛,严重危害人民健康。自从液体疗法应用于本病后,病死率已大大降低,但仍有不少患者未能幸免。近年来,随着本病发病机理研究的进展,本病的治疗学也取得了可喜的进步。近年来认为EHF的发病机理除与病毒直接作用有关外,免疫致病学说已为大多数学者所接受。其中除Ⅲ型变态反应外,Ⅰ、Ⅱ型变态反应的作用也不容忽视,因此提出了相应的免疫治疗方法,实验及临床研究证明,免疫疗法是行之有效的治疗方法,日益受到关注。
Overview Epidemic hemorrhagic fever (EHF) is an acute infectious disease that is prevalent in our country and seriously endangers people’s health. Since the application of liquid therapy to this disease, mortality has been greatly reduced, but there are still many patients were not spared. In recent years, with the progress of the pathogenesis of this disease, the treatment of this disease has also made gratifying progress. In recent years, in addition to the pathogenesis of EHF and the direct effect of the virus, the immune pathogenesis has been accepted by most scholars. In addition to the type Ⅲ allergic reaction, the role of type Ⅰ and type Ⅱ allergic reactions can not be ignored. Therefore, the corresponding immunotherapy methods have been put forward. Experiments and clinical studies have proved that immunotherapy is an effective treatment and attracts more and more attention.